IBTFvsIHE
iShares iBonds Dec 2025 Term Treasury ETF against iShares U.S. Pharmaceuticals ETF — the fee, the flows, the book, and a year head-to-head.
Head to head
| IBTF | IHE | |
|---|---|---|
| Expense ratio | 0.070% | 0.40% |
| Assets | $1.4B | $1.6B |
| Net flow, 1 month | — | −$14M |
| Net flow, 1 year | −$367M | +$756M |
| Return, YTD | — | +15.9% |
| Return, 1 year | 0.0% | +30.5% |
| Avg daily volume | — | 204K |
| Holdings | 32 | 38 |
| Listed | Feb 25, 2020 | May 1, 2006 |
| Options market | No | Yes |
MARKED CELLS LEAD ON THAT LINE · LOWER FEE, LARGER ASSETS, STRONGER FLOWS & RETURNS